Search for: "GD SEARLE " Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Dec 2017, 2:13 pm
  Andrew started with the year’s SPC cases (Abraxis, Teva v Gilead, Teva v Merck, Sandoz v GD Searle) before going on to the legal highlights: Actavis, AbbVie and Unwired Planet. [read post]
., GD Searle LLC [2008] APO 31), which followed the 2006 decision of a single judge of the Federal Court, Justice Bennett, in Pfizer Corp v Commissioner of Patents (No 2). [read post]
26 Apr 2018, 4:48 am by Laura Reynolds
What is not clear is the extent (if any) to which the AG had in mind the two other pending references***: Royalty Pharma’s application (C-650/17), which concerns an SPC for sitagliptin based upon a patent which did not individually disclose sitagliptin (indeed sitagliptin was developed after the priority date of the patent) and Sandoz v GD Searle ([2018] EWCA Civ 49) which concerns an SPC for darunavir based upon a patent which did not individually disclose darunavir but had… [read post]
19 Dec 2019, 9:41 am
The Court of Appeal pawing at a combination SPC this holidayseason ...It is the most wonderful time of the year. [read post]